CTEC · Pharma and healthcare · one day
Convatec (CTEC): news on Thursday 22 October 2026
News from the 24 hours to Thursday morning, 22 October 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on JP Morgan backing Convatec's full-year guidance ahead of a trading update, easing earlier worries, and shares rose and outperformed the market. Director purchases and a raised interim dividend added support, though an InnovaMatrix writedown was also mentioned.
What drove it
- JP Morgan guidance support
- pre-trading update
- director buying and dividend
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Fri 16 Oct | −1.8 | 2 |
| Sat 17 Oct | +1.3 | 2 |
| Sun 18 Oct | +2.0 | 1 |
| Tue 20 Oct | +7.0 | 1 |
| Wed 21 Oct | +5.0 | 2 |
| Thu 22 Oct | +8.0 | 6 |
| Fri 23 Oct | +6.3 | 1 |
| Sat 24 Oct | +4.5 | 2 |
| Sun 25 Oct | +3.0 | 1 |
3 stories · 6 headlines · strongest first
Pharma and healthcare on 22 OctoberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| JP Morgan backs Convatec guidance ahead of trading update +9.13 headlines today · Ahead of its trading update, Convatec's guidance appears more secure, according to JP Morgan. | ||
| +9.3 | Broker backing eases worries over full-year guidance. | |
| +9.2 | JP Morgan sees guidance as increasingly secure before trading update. | |
| +8.7 | JP Morgan backs 2026 earnings guidance. | |
| Convatec share repurchases and higher interim dividend +5.52 headlines today · 3 in all, since 14 October · Kalkine pieces discuss the InnovaMatrix writedown, raised dividend and director purchases. | ||
| +7.0 | Director purchases and buybacks suggest confidence in the company. | |
| +0.8 | InnovaMatrix writedown offset by higher interim dividend. | |
| Convatec shares rise Wednesday +5.81 headline today · MarketWatch says Convatec outperformed the market. | ||
| +5.8 | Shares rose and outperformed the market. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Convatec: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.